Tuesday, 02 January 2024 12:17 GMT

Billiontoone To Participate In Two Upcoming Investor Conferences


Date:

(MENAFN- GlobeNewsWire - Nasdaq) MENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company will participate in two upcoming investor conferences.

  • UBS Global Healthcare Conference 2026
    Fireside Chat on Tuesday, November 10th at 2:00 PM ET
  • Stifel 2026 Healthcare Conference
    Fireside Chat on Wednesday, November 11th at 3:20 PM ET

A live and archived webcast of the events will be available on the“Events” page of BillionToOne's investor relations website at .

About BillionToOne

Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting TemplatesTM (QCTTM) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit .

Investor Contact
...

Media Contact
...


MENAFN27102026004107003653ID1111872696


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search